Cargando…

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach

BACKGROUND: Genomics, transcriptomics and proteomics of glioblastoma multiforme (GBM) have recently emerged as possible tools to discover therapeutic targets and biomarkers for new therapies including immunotherapy. It is well known that macroscopically complete surgical excision, radiotherapy and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collet, Brigitte, Guitton, Nathalie, Saïkali, Stephan, Avril, Tony, Pineau, Charles, Hamlat, Abderrahmane, Mosser, Jean, Quillien, Véronique
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083325/ https://www.ncbi.nlm.nih.gov/pubmed/21470419 http://dx.doi.org/10.1186/1477-5956-9-16

Ejemplares similares

Overview of Cellular Immunotherapy for Patients with Glioblastoma
por: Vauleon, Elodie, et al.
Publicado: (2010)

Immune genes are associated with human glioblastoma pathology and patient survival
por: Vauléon, Elodie, et al.
Publicado: (2012)

DNA methylation in glioblastoma: impact on gene expression and clinical outcome
por: Etcheverry, Amandine, et al.
Publicado: (2010)

The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line
por: Monnier, Annabelle, et al.
Publicado: (2018)

Prognostic Significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, Four New Markers in High-Grade Gliomas
por: de Tayrac, Marie, et al.
Publicado: (2013)

Circadian Profiling of the Arabidopsis Proteome Using 2D-DIGE
por: Choudhary, Mani K., et al.
Publicado: (2016)

Bone Marrow-Derived Mesenchymal Stem Cells Differentially Affect Glioblastoma Cell Proliferation, Migration, and Invasion: A 2D-DIGE Proteomic Analysis
por: Li, Shenjie, et al.
Publicado: (2021)

Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2019)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Proteomic Changes during B Cell Maturation: 2D-DIGE Approach
por: Salonen, Johanna, et al.
Publicado: (2013)

2D-DIGE proteome analysis on the platelet proteins of patients with major depression
por: Huang, Tiao-Lai, et al.
Publicado: (2014)

‘From the core to beyond the margin’: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2015)

Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis
por: Lim, Lay Cheng, et al.
Publicado: (2015)

Differential in Gel Electrophoresis (DIGE) Comparative Proteomic Analysis of Macrophages Cell Cultures in Response to Perthamide C Treatment
por: Vilasi, Annalisa, et al.
Publicado: (2013)

Correction: From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2016)

Assessment of the Red Cell Proteome of Young Patients with Unexplained Hemolytic Anemia by Two-Dimensional Differential In-Gel Electrophoresis (DIGE)
por: von Löhneysen, Katharina, et al.
Publicado: (2012)

Post-ovulatory ageing and egg quality: A proteomic analysis of rainbow trout coelomic fluid
por: Rime, Hélène, et al.
Publicado: (2004)

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2014)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

A DIGE study on the effects of salbutamol on the rat muscle proteome - an exemplar of best practice for data sharing in proteomics
por: Kenyani, Jenna, et al.
Publicado: (2011)

Dual IRE1 RNase functions dictate glioblastoma development
por: Lhomond, Stéphanie, et al.
Publicado: (2018)

Investigating Glioblastoma Multiforme Sub-Proteomes: A Computational Study of CUSA Fluid Proteomic Data
por: Moresi, Fabiana, et al.
Publicado: (2022)

2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma
por: Poli, Giada, et al.
Publicado: (2015)

Comparative proteomics analysis of human osteosarcoma by 2D DIGE with MALDI-TOF/TOF MS
por: Wang, Guoxiang, et al.
Publicado: (2016)

Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome
por: Pooladi, Mehdi, et al.
Publicado: (2014)

A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme
por: de Aquino, Priscila F., et al.
Publicado: (2016)

Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature
por: Syafruddin, Saiful Effendi, et al.
Publicado: (2021)

Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma
por: MAYER, ARNULF, et al.
Publicado: (2012)

Differential Effects of Wedelia chinensis on Human Glioblastoma Multiforme Cells
por: Chen, Li-Jeng, et al.
Publicado: (2021)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_imetpp2f6n36a82564poh9h590